BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12455467)

  • 1. Properties of ibuprofen crystallized under various conditions: a comparative study.
    Rasenack N; Müller BW
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1077-89. PubMed ID: 12455467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibuprofen crystals with optimized properties.
    Rasenack N; Müller BW
    Int J Pharm; 2002 Oct; 245(1-2):9-24. PubMed ID: 12270238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and in vivo evaluation of pharmacological activity of different crystal forms of ibuprofen.
    Li Y; Yao F; Shang C; Ren F; Zhang J; Li Y; Yang G; Lin R; Wang W
    Pak J Pharm Sci; 2019 Sep; 32(5):2139-2147. PubMed ID: 31813880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, and evaluation of physicochemical properties of different crystalline forms of ibuprofen.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):463-71. PubMed ID: 9876609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal habit modifications of ibuprofen and their physicomechanical characteristics.
    Garekani HA; Sadeghi F; Badiee A; Mostafa SA; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2001 Sep; 27(8):803-9. PubMed ID: 11699831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers.
    Kachrimanis K; Nikolakakis I; Malamataris S
    J Pharm Sci; 2000 Feb; 89(2):250-9. PubMed ID: 10688754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
    Bukovec P; Benkic P; Smrkolj M; Vrecer F
    Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibuprofen agglomerates preparation by phase separation.
    Jbilou M; Ettabia A; Guyot-Hermann AM; Guyot JC
    Drug Dev Ind Pharm; 1999 Mar; 25(3):297-305. PubMed ID: 10071822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal modification of phenytoin using different solvents and crystallization conditions.
    Nokhodchi A; Bolourtchian N; Dinarvand R
    Int J Pharm; 2003 Jan; 250(1):85-97. PubMed ID: 12480275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal modification of dipyridamole using different solvents and crystallization conditions.
    Adhiyaman R; Basu SK
    Int J Pharm; 2006 Sep; 321(1-2):27-34. PubMed ID: 16842943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of solvent on the morphology and subsequent comminution of ibuprofen crystals by air jet milling.
    Shariare MH; Blagden N; de Matas M; Leusen FJ; York P
    J Pharm Sci; 2012 Mar; 101(3):1108-19. PubMed ID: 22161641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal modifications and dissolution rate of piroxicam.
    Lyn LY; Sze HW; Rajendran A; Adinarayana G; Dua K; Garg S
    Acta Pharm; 2011 Dec; 61(4):391-402. PubMed ID: 22202198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocrystal habit engineering to improve drug dissolution and alter derived powder properties.
    Serrano DR; O'Connell P; Paluch KJ; Walsh D; Healy AM
    J Pharm Pharmacol; 2016 May; 68(5):665-77. PubMed ID: 26408342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial salt screening procedures for manufacturing ibuprofen.
    Lee T; Wang YW
    Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melt sonocrystallization of ibuprofen: effect on crystal properties.
    Manish M; Harshal J; Anant P
    Eur J Pharm Sci; 2005 May; 25(1):41-8. PubMed ID: 15854799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound-assisted preparation of novel ibuprofen-loaded excipient with improved compression and dissolution properties.
    Gandhi P; Patil S; Aher S; Paradkar A
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1553-63. PubMed ID: 26858024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol.
    Sai Gouthami K; Kumar D; Thipparaboina R; Chavan RB; Shastri NR
    Int J Pharm; 2015 Aug; 491(1-2):26-34. PubMed ID: 26068197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of crystal habit of ibuprofen using the phase partition technique: effect of aerosil and tween 80 in binding solvent.
    Umprayn K; Luengtummuen A; Kitiyadisai C; Pornpiputsakul T
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1047-56. PubMed ID: 11794807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation and compression characteristics of prismatic polyhedral and thin plate-like crystals of paracetamol.
    Garekani HA; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Int J Pharm; 1999 Sep; 187(1):77-89. PubMed ID: 10502615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved dissolution behavior of fenbufen by spherical crystallization.
    Di Martino P; Barthélémy C; Piva F; Joiris E; Palmieri GF; Martelli S
    Drug Dev Ind Pharm; 1999 Oct; 25(10):1073-81. PubMed ID: 10529887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.